Publication | Closed Access

Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis

Pulmonary TuberculosisVirulent Mycobacterium TuberculosisWhole-bacterium SelexHealth SciencesImmunologyTuberculosisNew Therapeutic ReagentAntibacterial AgentMicrobiologyMedicineClinical MicrobiologyAntimicrobial ResistanceDrug DiscoveryDrug Resistance